© 2019 Santen Inc. All rights reserved. PP-GLAU-US-0037
References: 1. Chan JE, Netland PA. EX-PRESS Glaucoma Filtration Device: efficacy, safety, and predictability. Med Devices (Auckl). 2015;8:381-388. 2. Lee RMH, Bouremel Y, Eames I, Brocchini
S, Kaw PT. The implications of an ab interno versus ab externo surgical approach on outflow resistance of a subconjunctival drainage device for intraocular pressure control. Transl Vis Sci Technol.
2019;8(3):58. 3. Amoozgar B, Wei X, Lee JH, et al. A novel flexible microfluidic meshwork to reduce fibrosis in glaucoma surgery. PLoS One. 2017;12(3):e0172556. 4. Agrawal P, Bradshaw SE.
Systematic literature review of clinical and economic outcomes of micro-invasive glaucoma surgery (MIGS) in primary open-angle glaucoma. Ophthalmol Ther. 2018;7(1):49-73.
Hear from your peers and register for more information at
AdvancingGlaucomaSurgery.com
PROACTIVE SURGERY PREDICTIBILITY SUSTAINABILITY DEVICE INNOVATION
PREDICTABILITY
• A minimally invasive device would help
mitigate trauma and expedite recovery
1
• Subconjunctival drainage is a proven
method to achieve target IOP
2
SUSTAINABILITY
• Device design could help maximize
outflow while minimizing hypotony
3,4
• Biocompatible material that resists
degradation could help deliver
more-sustainable benefits
3
PREDICTIBILITY SUSTAINABILITY DEVICE INNOVATION
W O R K I N G T O E M P O W E R A N E W E R A O F
GLAUCOMA SURGICAL DEVICE INNOVATION
We're dedicated to advancing proactive glaucoma surgery by working toward
more predictable and sustainable outcomes
